Mixed‐effects models for slope‐based endpoints in clinical trials of chronic kidney disease

%JM: A SAS Macro to Fit Jointly Generalized Mixed Models for Longitudinal Data and Time-to-Event Responses

(2018) Alberto Garcia-Hernandez et al.   Journal of Statistical Software

Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough

(2015) Gabriel Thabut et al.   EUROPEAN RESPIRATORY JOURNAL

JM: AnRPackage for the Joint Modelling of Longitudinal and Time-to-Event Data

(2015) Dimitris Rizopoulos   Journal of Statistical Software

Utility and Validity of Estimated GFR–Based Surrogate Time-to-Event End Points in CKD: A Simulation Study

(2014) Tom Greene et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials

(2014) Hiddo J. Lambers Heerspink et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials

(2014) Lesley A. Inker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

(2014) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Fixed-effect variable selection in linear mixed models using statistics

(2007) Jean G. Orelien et al.   COMPUTATIONAL STATISTICS & DATA ANALYSIS